Elmer Flores
Medical · Tamarac, FLNPI 1932414059
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,815 of the $6,521 with a category attached, or 89.2%. It is spread thinly across 39 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,172 and has fallen 58.8% since, to $895 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$848
- Exelixis Inc.$704
- Eisai Inc.$432
- Incyte Corporation$401
- AbbVie$358
- AstraZeneca$345
- plus $3K from 33 others
What the payments were for
- Food & beverage$5,81589%
- Education$70611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 36 | $848 |
| Exelixis Inc. | 24 | $704 |
| Eisai Inc. | 19 | $432 |
| Incyte Corporation | 17 | $401 |
| AbbVie | 18 | $358 |
| AstraZeneca | 15 | $345 |
| Lilly USA, LLC | 15 | $309 |
| Jazz Pharmaceuticals Inc. | 19 | $305 |
| Pfizer | 19 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $264 |
| Seagen Inc. | 11 | $237 |
| E.r. Squibb & Sons, L.L.C. | 9 | $194 |
| Merck | 7 | $135 |
| Bayer | 6 | $122 |
| Sobi, Inc | 4 | $119 |
| Amgen | 8 | $117 |
| GSK | 1 | $117 |
| Sanofi | 5 | $111 |
| Bristol Myers Squibb | 6 | $111 |
| Mirati Therapeutics, Inc. | 6 | $106 |
| Puma Biotechnology, Inc. | 5 | $94 |
| Tolmar Pharmaceuticals, Inc. | 4 | $81 |
| Servier Pharmaceuticals LLC | 3 | $70 |
| Stemline Therapeutics Inc. | 3 | $70 |
| Deciphera Pharmaceuticals Inc. | 3 | $61 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Myriad Genetic Laboratories, Inc. | 3 | $56 |
| Genentech USA, Inc. | 2 | $52 |
| Novartis | 3 | $52 |
| Array Biopharma Inc | 4 | $52 |
| Foundation Medicine, Inc. | 3 | $49 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Adaptive Biotechnologies Corporation | 2 | $38 |
| Caris MPI, Inc. | 1 | $26 |
| Immunogen, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Organon | 1 | $21 |
| Geron Corporation | 1 | $21 |
| Myovant Sciences Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,521 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 14 | $719 |
| Methylprednisolone | 13 | $44 |
| Furosemide | 17 | $12 |
Paid to pharmacies, not to this prescriber.
Other medical in Tamarac
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.